[A new combination of methotrexate and folinic acid for cancer treatment (acute leukemia and solid tumors)].
D000380:Agranulocytosis / Q000209:etiology; D000970:Antineoplastic Agents; D001943:Breast Neoplasms / Q000188:drug therapy; D005260:Female; D006394:Hemangiosarcoma / Q000188:drug therapy; D006689:Hodgkin Disease / Q000188:drug therapy*; D006801:Humans; D007680:Kidney Neoplasms / Q000188:drug therapy; D002955:Leucovorin / Q000008:administration & dosage*; D007945:Leukemia, Lymphoid / Q000188:drug therapy*; D007948:Leukemia, Monocytic, Acute / Q000188:drug therapy; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy*; D008175:Lung Neoplasms / Q000000981:diagnostic imaging; D016403:Lymphoma, Large B-Cell, Diffuse / Q000188:drug therapy; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy; D008297:Male; D008545:Melanoma / Q000188:drug therapy; D008727:Methotrexate / Q000008:administration & dosage*; D012516:Osteosarcoma / Q000188:drug therapy; D010190:Pancreatic Neoplasms / Q000188:drug therapy; D011859:Radiography; D012004:Rectal Neoplasms / Q000188:drug therapy; D012208:Rhabdomyosarcoma / Q000188:drug therapy; D013736:Testicular Neoplasms / Q000188:drug therapy; D013921:Thrombocytopenia / Q000209:etiology
D000970:Antineoplastic Agents; D002955:Leucovorin; D008727:Methotrexate
Une nouvelle combinaison de méthotrexate et d'acide folnique pour le traitement des cancers. (Leucémies aiguës et tumeurs solides)